|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 487/04 | |
| A61K 31/55 | |||
| A61P 35/00 |
| (11) | Patento numeris | 2944639 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15155821.0 |
| Europos patento paraiškos padavimo data | 2007-11-14 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-11-18 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-01-04 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 859340 P | 2006-11-16 | US |
| (72) |
CLAIBORNE, Christopher F., US
SELLS, Todd B., US
STROUD, Stephen G., US
|
| (73) |
MILLENNIUM PHARMACEUTICALS, INC.,
40 Landsdowne Street, Cambridge, MA 02139,
US
|
| (54) | Compound for inhibiting mitotic progression |
| Compound for inhibiting mitotic progression |